Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL21806100

NCCCOCCOCCOCCCNC(=O)c1ccc2nonc2c1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.49
▸ HDAC1 Q13547 1/20 0.49
▸ ADORA3 P0DMS8 1/20 0.48
▸ ADORA2A P29274 1/20 0.48
▸ ADORA2B P29275 1/20 0.48
▸ ADORA1 P30542 1/20 0.48
▸ DRD3 P35462 7/20 0.46
▸ DRD2 P14416 4/20 0.46
▸ MAPT P10636 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ HPGD P15428 5/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ HTT P42858 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HDAC4 P56524 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24012442 0.83 HPGD (0.61) HDAC3HDAC1ADORA3ADORA2AADORA2B
Trifluoroacetic Acid SCHEMBL5903474 0.82 SMN1; SMN2 (0.44) MAPTHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL13081990 0.78 ADORA3 (0.62) HDAC3HDAC1ADORA3ADORA2AADORA2B
SCHEMBL13056379 0.77 ADORA3 (0.55) HDAC3HDAC1ADORA3ADORA2AADORA2B
SCHEMBL13248222 0.75 ADORA3 (0.56) HDAC3HDAC1ADORA3ADORA2AADORA2B
SCHEMBL13248219 0.75 ADORA3 (0.55) HDAC3HDAC1ADORA3ADORA2AADORA2B
SCHEMBL13056382 0.74 HDAC3 (0.50) HDAC3HDAC1ADORA3ADORA2AADORA2B
SCHEMBL13248218 0.74 ADORA3 (0.54) HDAC3HDAC1ADORA3ADORA2AADORA2B
SCHEMBL8816476 0.71 HPGD (0.55) HPGDNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6028978 0.70 ADORA3 (0.62) HDAC3HDAC1ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210349101-A1 COUMARIN-BASED CROSSLINKING REAGENTS VENTANA MEDICAL SYSTEMS, INC. 2021-11-11 — — US disclosed
EP-3853214-A1 COUMARIN-BASED CROSSLINKING REAGENTS Ventana Medical Systems, Inc. (US) 2021-07-28 — — EP disclosed
WO-2020058339-A1 COUMARIN-BASED CROSSLINKING REAGENTS VENTANA MEDICAL SYSTEMS, INC. (US) 2020-03-26 — — WO disclosed
Send feedback